Amendment No. 13 to Schedule 13D for REVIVA PHARMACEUTICALS HOLDINGS, INC.

This filing is an amendment to a previous Schedule 13D, filed by Parag Saxena, regarding his beneficial ownership of Reviva Pharmaceuticals Holdings, Inc. common stock. As of March 24, 2026, Mr. Saxena beneficially owns 363,280 shares, representing approximately 2.8% of the outstanding shares. This ownership includes directly held shares, shares held by various entities, and shares underlying warrants and options exercisable within 60 days. The filing notes that Mr. Saxena ceased to be a beneficial holder of more than five percent of the Issuer's Common Stock on March 20, 2026. No transactions were effected by the Reporting Person in the past sixty days. The filing incorporates information from previous amendments and the cover pages regarding shareholdings and ownership percentages. The information regarding beneficial ownership is based on 12,810,377 outstanding shares as of March 20, 2026.